US Stock MarketDetailed Quotes

ProQR Therapeutics (PRQR)

Watchlist
  • 1.600
  • -0.010-0.62%
Close May 12 16:00 ET
  • 1.600
  • 0.0000.00%
Post 16:10 ET
168.58MMarket Cap-3.40P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ProQR Therapeutics (PRQR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-15.86%15.91M
8.85%4.69M
-25.01%2.88M
-39.46%3.82M
1.55%4.52M
190.22%18.91M
31.15%4.31M
180.51%3.84M
423.24%6.31M
579.39%4.45M
Operating revenue
-15.86%15.91M
8.85%4.69M
-25.01%2.88M
-39.46%3.82M
1.55%4.52M
190.22%18.91M
31.15%4.31M
180.51%3.84M
423.24%6.31M
579.39%4.45M
Cost of revenue
Gross profit
Operating expense
20.20%59.35M
-4.19%13.79M
12.80%14.17M
62.20%16.07M
22.44%15.34M
19.55%49.38M
15.26%14.39M
43.35%12.56M
-1.11%9.91M
24.70%12.53M
Selling and administrative expenses
10.24%15.06M
-0.56%3.89M
-5.00%3.12M
59.84%4.82M
-6.32%3.23M
-15.86%13.66M
-17.62%3.91M
-0.97%3.28M
-27.31%3.01M
-14.26%3.45M
-General and administrative expense
10.24%15.06M
-0.56%3.89M
-5.00%3.12M
59.84%4.82M
-6.32%3.23M
-15.86%13.66M
-17.62%3.91M
-0.97%3.28M
-27.31%3.01M
-14.26%3.45M
Research and development costs
23.04%44.73M
-6.49%9.92M
17.70%11.08M
61.86%11.41M
32.75%12.32M
44.57%36.36M
37.22%10.61M
72.86%9.41M
19.28%7.05M
53.18%9.28M
Other operating expenses
31.09%-441K
79.41%-28K
76.09%-33K
-1.28%-158K
-5.71%-222K
-700.00%-640K
---136K
---138K
-310.53%-156K
-400.00%-210K
Operating profit
-42.58%-43.45M
9.76%-9.1M
-29.46%-11.28M
-240.25%-12.25M
-33.94%-10.82M
12.41%-30.47M
-9.59%-10.08M
-17.93%-8.72M
59.14%-3.6M
14.00%-8.08M
Net non-operating interest income expense
-35.42%1.4M
-32.24%477K
-40.30%280K
-62.57%192K
-6.76%455K
56.40%2.17M
-36.06%704K
29.20%469K
9.15%513K
189.71%488K
Non-operating interest income
-28.24%2.33M
----
----
----
----
25.38%3.25M
----
----
----
----
Non-operating interest expense
-13.74%929K
----
----
----
----
-10.47%1.08M
----
----
----
----
Total other finance cost
----
----
40.30%-280K
62.57%-192K
6.76%-455K
----
----
-29.20%-469K
-9.15%-513K
-189.71%-488K
Other net income (expense)
-136.39%-123K
-515.28%-299K
-101.44%-2K
-153.33%-104K
514.71%282K
-93.95%338K
-97.25%72K
-91.13%139K
-39.44%195K
-106.31%-68K
Gain on sale of security
-5,014.29%-358K
----
----
----
----
97.25%-7K
123.15%72K
17.80%139K
-11.76%195K
-110.15%-68K
Earnings from equity interest
----
----
----
----
----
--0
--0
--0
--0
----
Special income (charges)
--0
----
----
----
----
--0
--0
--0
--0
--0
-Gain on sale of business
--0
----
----
----
----
--0
--0
--0
----
----
-Gain on sale of property,plant,equipment
--0
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
-31.88%235K
-25.32%59K
-101.44%-2K
-153.33%-104K
514.71%282K
-63.80%345K
241.07%79K
17.80%139K
-11.76%195K
-110.15%-68K
Income before tax
-50.80%-42.17M
4.15%-8.92M
-35.74%-11.01M
-320.50%-12.16M
-31.67%-10.08M
-0.53%-27.96M
-69.86%-9.31M
-48.47%-8.11M
63.94%-2.89M
13.55%-7.66M
Income tax
109.64%19K
1K
0
109.00%18K
0
-152.56%-197K
0
0
-376.19%-200K
3K
Net income
-51.94%-42.18M
4.14%-8.92M
-35.74%-11.01M
-352.41%-12.18M
-31.61%-10.08M
-0.10%-27.76M
-69.71%-9.31M
-49.59%-8.11M
66.25%-2.69M
13.52%-7.66M
Net income continuous Operations
-51.94%-42.18M
4.14%-8.92M
-35.74%-11.01M
-352.41%-12.18M
-31.61%-10.08M
-0.10%-27.76M
-69.71%-9.31M
-49.59%-8.11M
66.25%-2.69M
13.52%-7.66M
Minority interest income
0
0
0
0
0
0
0
0
0
0
Net income attributable to the parent company
-51.94%-42.18M
4.14%-8.92M
-35.74%-11.01M
-352.41%-12.18M
-31.61%-10.08M
1.27%-27.76M
-69.71%-9.31M
-42.00%-8.11M
66.32%-2.69M
14.27%-7.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-51.94%-42.18M
4.14%-8.92M
-35.74%-11.01M
-352.41%-12.18M
-31.61%-10.08M
1.27%-27.76M
-69.71%-9.31M
-42.00%-8.11M
66.32%-2.69M
14.27%-7.66M
Basic earnings per share
-25.00%-0.4
11.11%-0.08
0.00%-0.1
-300.00%-0.12
-11.11%-0.1
8.57%-0.32
-28.57%-0.09
-42.86%-0.1
70.00%-0.03
18.18%-0.09
Diluted earnings per share
-25.00%-0.4
11.11%-0.08
0.00%-0.1
-300.00%-0.12
-11.11%-0.1
8.57%-0.32
-28.57%-0.09
-42.86%-0.1
70.00%-0.03
18.18%-0.09
Dividend per share
Currency Unit
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
EUR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -15.86%15.91M8.85%4.69M-25.01%2.88M-39.46%3.82M1.55%4.52M190.22%18.91M31.15%4.31M180.51%3.84M423.24%6.31M579.39%4.45M
Operating revenue -15.86%15.91M8.85%4.69M-25.01%2.88M-39.46%3.82M1.55%4.52M190.22%18.91M31.15%4.31M180.51%3.84M423.24%6.31M579.39%4.45M
Cost of revenue
Gross profit
Operating expense 20.20%59.35M-4.19%13.79M12.80%14.17M62.20%16.07M22.44%15.34M19.55%49.38M15.26%14.39M43.35%12.56M-1.11%9.91M24.70%12.53M
Selling and administrative expenses 10.24%15.06M-0.56%3.89M-5.00%3.12M59.84%4.82M-6.32%3.23M-15.86%13.66M-17.62%3.91M-0.97%3.28M-27.31%3.01M-14.26%3.45M
-General and administrative expense 10.24%15.06M-0.56%3.89M-5.00%3.12M59.84%4.82M-6.32%3.23M-15.86%13.66M-17.62%3.91M-0.97%3.28M-27.31%3.01M-14.26%3.45M
Research and development costs 23.04%44.73M-6.49%9.92M17.70%11.08M61.86%11.41M32.75%12.32M44.57%36.36M37.22%10.61M72.86%9.41M19.28%7.05M53.18%9.28M
Other operating expenses 31.09%-441K79.41%-28K76.09%-33K-1.28%-158K-5.71%-222K-700.00%-640K---136K---138K-310.53%-156K-400.00%-210K
Operating profit -42.58%-43.45M9.76%-9.1M-29.46%-11.28M-240.25%-12.25M-33.94%-10.82M12.41%-30.47M-9.59%-10.08M-17.93%-8.72M59.14%-3.6M14.00%-8.08M
Net non-operating interest income expense -35.42%1.4M-32.24%477K-40.30%280K-62.57%192K-6.76%455K56.40%2.17M-36.06%704K29.20%469K9.15%513K189.71%488K
Non-operating interest income -28.24%2.33M----------------25.38%3.25M----------------
Non-operating interest expense -13.74%929K-----------------10.47%1.08M----------------
Total other finance cost --------40.30%-280K62.57%-192K6.76%-455K---------29.20%-469K-9.15%-513K-189.71%-488K
Other net income (expense) -136.39%-123K-515.28%-299K-101.44%-2K-153.33%-104K514.71%282K-93.95%338K-97.25%72K-91.13%139K-39.44%195K-106.31%-68K
Gain on sale of security -5,014.29%-358K----------------97.25%-7K123.15%72K17.80%139K-11.76%195K-110.15%-68K
Earnings from equity interest ----------------------0--0--0--0----
Special income (charges) --0------------------0--0--0--0--0
-Gain on sale of business --0------------------0--0--0--------
-Gain on sale of property,plant,equipment --0------------------0----------------
Other non- operating income (expenses) -31.88%235K-25.32%59K-101.44%-2K-153.33%-104K514.71%282K-63.80%345K241.07%79K17.80%139K-11.76%195K-110.15%-68K
Income before tax -50.80%-42.17M4.15%-8.92M-35.74%-11.01M-320.50%-12.16M-31.67%-10.08M-0.53%-27.96M-69.86%-9.31M-48.47%-8.11M63.94%-2.89M13.55%-7.66M
Income tax 109.64%19K1K0109.00%18K0-152.56%-197K00-376.19%-200K3K
Net income -51.94%-42.18M4.14%-8.92M-35.74%-11.01M-352.41%-12.18M-31.61%-10.08M-0.10%-27.76M-69.71%-9.31M-49.59%-8.11M66.25%-2.69M13.52%-7.66M
Net income continuous Operations -51.94%-42.18M4.14%-8.92M-35.74%-11.01M-352.41%-12.18M-31.61%-10.08M-0.10%-27.76M-69.71%-9.31M-49.59%-8.11M66.25%-2.69M13.52%-7.66M
Minority interest income 0000000000
Net income attributable to the parent company -51.94%-42.18M4.14%-8.92M-35.74%-11.01M-352.41%-12.18M-31.61%-10.08M1.27%-27.76M-69.71%-9.31M-42.00%-8.11M66.32%-2.69M14.27%-7.66M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -51.94%-42.18M4.14%-8.92M-35.74%-11.01M-352.41%-12.18M-31.61%-10.08M1.27%-27.76M-69.71%-9.31M-42.00%-8.11M66.32%-2.69M14.27%-7.66M
Basic earnings per share -25.00%-0.411.11%-0.080.00%-0.1-300.00%-0.12-11.11%-0.18.57%-0.32-28.57%-0.09-42.86%-0.170.00%-0.0318.18%-0.09
Diluted earnings per share -25.00%-0.411.11%-0.080.00%-0.1-300.00%-0.12-11.11%-0.18.57%-0.32-28.57%-0.09-42.86%-0.170.00%-0.0318.18%-0.09
Dividend per share
Currency Unit EUREUREUREUREUREUREUREUREUREUR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +24.74%
Sample Name
Sample Code
 +22.84%
Sample Name
Sample Code
 +19.74%
4
United States Oil Fund LP
USO
+16.51%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+14.47%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.63%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +6.10%
4
Li Auto
LI
+5.40%
5
Vipshop
VIPS
+3.19%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting an immediate response from Iran: no one Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -